Halozyme Therapeutics, Inc. (HALO)
70.49
-0.99
(-1.39%)
USD |
NASDAQ |
Jun 10, 16:00
70.53
+0.04
(+0.06%)
After-Hours: 16:15
Halozyme Therapeutics EPS Diluted (TTM) : 2.780 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 16.87 |
| Agenus, Inc. | 1.670 |
| Altimmune, Inc. | -0.9376 |
| Lineage Cell Therapeutics, Inc. | -0.2873 |
| Amgen, Inc. | 14.38 |